TinyGemsBreaks Archive - Page 51 of 129

ThursdayOct 12, 2023 1:30 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs and K1B Emergency Communications Systems Deployed for New and Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced two new sales for its K5 ASRs and an expansion sale from an existing user of its K1B line of emergency communication systems. The announcement reads, “Two Portland, Oregon, hotels each signed contracts for Knightscope ASRs to patrol their parking areas after the word-of-mouth-success of another Portland area hotel. Security in hospitality encompasses a hotel’s building and grounds as well as its guests, employees, visitors and day users. As recently outlined in Knightscope’s Blog, operators and administrators must follow an integrated approach…

ThursdayOct 12, 2023 12:57 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Portfolio Expansion to 37 Granted Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted patents. According to the update, Canadian Patent #2,984,917, “ Stable Ready-to-drink Beverage Compositions Comprising Lipophilic Active Agents, ” was granted on Sept. 26, 2023, and expires Dec. 1, 2036. The patent recognizes Lexaria’s innovations in delivering lipophilic (fat-based) active drugs and active molecules suspended in a water-based format. Lexaria’s DehydraTECH technology can be used in dry formats such as capsules and pills, as well as…

WednesdayOct 11, 2023 1:34 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being enrolled in 46 clinical trial sites across the United States, Italy, France, Spain and Switzerland. According to the announcement, CNS Pharmaceuticals is on track to achieve value-driving milestones before the end of the year, including…

MondayOct 09, 2023 1:07 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems Deployed for Four Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels must do everything they can to ensure that schools are safe places for students, teachers and other employees. A university in Delaware is expanding their 15-phone emergency communication system with 3 K1 Blue Light Emergency Phones. A Southern California university added Knightscope’s K1B Maintenance Plan…

MondayOct 09, 2023 11:47 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Marianne McInerney as Chief Strategy Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the appointment of Marianne McInerney as chief strategy officer. According to the announcement, McInerney will focus on growth opportunities and drive strategic initiatives for Mullen’s commercial, consumer vehicles and governmental affairs. McInerney has nearly two decades of experience in the automotive and transportation industry, during which she has advised multiple original equipment manufacturers, governmental entities and tier one suppliers and held vital positions at next-generation vehicle OEMs, the U.S. Department of Transportation, and the American International Automobile Dealers Association. “Marianne is a key addition to our team and…

FridayOct 06, 2023 11:30 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Growth, Momentum with New Emergency Communications Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is seeing consistent success and growth as the company has announced a string of new orders. Most recently, the company has signed three new contracts for five devices to be used by clients in New York, Nevada, and Oklahoma. The new orders represent the value and diversity Knightscope products for an array of uses and across a broad spectrum. The Knightscope devices will be used on a college campus in New York, a park in Oklahoma and a city in Nevada. “The goal of…

WednesdayOct 04, 2023 3:23 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASR, K1 Hemisphere for New Contracts in Southern California

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced two new contracts from a Los Angeles area shopping center and a medical clinic. The announcement reads, “The Knightscope K5 Autonomous Security Robot (‘ASR’) will be patrolling the interior of a large, cultural mall in the Los Angeles area. Shopping centers are places where people go to shop, dine, relax, browse or meet in a fun and safe atmosphere. Providing that safe environment reduces vacancies, mitigates risk, elevates property values and increases foot traffic. Knightscope ASRs have already successfully deterred substance abuse,…

WednesdayOct 04, 2023 1:59 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) to Unveil Encouraging Data on REQORSA(R) for Lung Cancer Treatment at 2023 AACR-NIH-EORTC Conference

Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compelling clinical and preclinical data at the prestigious 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 11-15 at the Hynes Convention Center in Boston. The Acclaim-1 Phase 1 study results have demonstrated the safety and efficacy of REQORSA(R) in combination with Tagrisso(R), bringing hope to patients with late-stage NSCLC. Moreover, preclinical studies have highlighted REQORSA(R)'s potential in combination with a checkpoint inhibitor to combat chemotherapy-resistant small cell lung…

TuesdayOct 03, 2023 4:02 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems to Bolster Public Safety Programs in Healthcare and Education

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced three new sales for its K1B Emergency Communications Systems. According to the update, the orders were placed by a college in Pennsylvania and two hospital systems – one in Illinois and one in Indiana. The announcement reads, “Healthcare organizations across the U.S. have partnered with Knightscope for many years to make advancements in various critical areas of physical security and emergency communications while improving patient satisfaction. The adoption of such technologies is aiding healthcare organizations to maintain or increase their HCAHPS scores…

TuesdayOct 03, 2023 12:16 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Announces Partnership with Aurora Geosciences to Confirm Resources, Increase Asset Value

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a 50% partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), is partnering with Aurora Geosciences to complete S-K 1300 technical reports on four assets. According to the announcement, two of GEMXX’s gold reserves along with two of its largest ammolite gemstone claims have not yet confirmed by an engineer report. Because of that, while these properties are owned and operated by GEMXX, they are not reflected on the company's balance sheet and no value has been recorded for the resources they contain. In order to accurately…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks